KR830007514A - 두고리 화합물의 제조방법 - Google Patents

두고리 화합물의 제조방법 Download PDF

Info

Publication number
KR830007514A
KR830007514A KR1019810004142A KR810004142A KR830007514A KR 830007514 A KR830007514 A KR 830007514A KR 1019810004142 A KR1019810004142 A KR 1019810004142A KR 810004142 A KR810004142 A KR 810004142A KR 830007514 A KR830007514 A KR 830007514A
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
hydrogen
hydroxyl
Prior art date
Application number
KR1019810004142A
Other languages
English (en)
Other versions
KR880000890B1 (ko
Inventor
요시까즈 오까
고헤이 니시가와
아끼오 미야께
Original Assignee
구라바야시 이꾸시로
다께다야꾸힝 고오교 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55154394A external-priority patent/JPS5777651A/ja
Priority claimed from JP56064371A external-priority patent/JPS57179141A/ja
Application filed by 구라바야시 이꾸시로, 다께다야꾸힝 고오교 가부시끼 가이샤 filed Critical 구라바야시 이꾸시로
Publication of KR830007514A publication Critical patent/KR830007514A/ko
Priority to KR1019860009085A priority Critical patent/KR880001007B1/ko
Application granted granted Critical
Publication of KR880000890B1 publication Critical patent/KR880000890B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

내용 없음

Description

두고리 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. (a) 하기식(Ⅱ)의 화합물 및 하기식(Ⅲ)의 화합물을 환원 조건하 축합 시키거나,
    (b) 식(Ⅰ)의 화합물〔여기서, R3는 수소이거나 또는 R6가 히드록실이며, R3가 수소이고, 기타 모든 상징은 하기 정의한 바와 같음.〕을 제공하기 위하여 식(Ⅰ)의 에스테르 화합물〔여기서, R3는 C1∼4알킬이거나 또는 R6가 C1∼4알콕시이며, R3가 C1∼4알킬이고, 기타 모든 상징은 하기 정의한 바와 같음〕을 가수분해 하거나,
    (c) 식(Ⅰ)의 화합물〔여기서, R3는 수소이거나 또는 R6가 히드록실이며, R3가 수소이고, 기타 모든 상징은 하기 정의한 바와 같음.〕을 제공하기 위하여 식(Ⅰ)〔여기서, R3는 벤질이거나 또는 R6가 벤질옥시이며 R3가 벤질이고, 기타 모든 상징은 하기 정의한 바와 같음〕의 화합물의 벤질 에스테르를 촉매 환원 시키거나,
    (d) 하기식(Ⅳ)의 화합물 가수분해 또는 촉매 환원 시키거나,
    (e) 식(Ⅱ)의 화합물을 하기식(Ⅴ)의 화합물과 반응시키고, 그리고
    (f) 원한다면, 이와 같이 얻은 식(Ⅰ)의 화합물을 약학적으로 무독한 그의 염으로 전환 시킴을 특징으로 하는 하기식(Ⅱ)의 두고리 화합물 또는 약학적으로 무독한 그의 염의 제조방법.
    (식중,
    R1및 R2는 독립적으로 수소, 히드록실 또는 C1-4알킬렌 디옥시를 나타내고,
    R3는 수소 또는 C1-4알킬이고,
    R4는 비치환 또는 C2-4알카노일, 벤조일, C2-4알콕시카르보닐 또는 벤질옥시카르보닐로 이루어진 종류의 아실에 의하여 치환된 C1-4알킬, 아미노 C1-4알킬, 또는 수소이고,
    R5는 비치환 또는 할로겐, C1-4알킬, C1-4알콕시, 아미노, 니트로 및 히드록실 중 1내지 3개로 치환된 C1-4알킬, 페닐 C1-4알킬 또는 할로겐이고,
    R6는 히드록실, C1-4알킬시, 아미노 또는 모노-또는 디 C1-4알킬아미노이고,
    X는 할로겐 또는 R7는 C1-4알킬, 페닐 또는 p-톨릴인 식 R7SO2-0-의 기이고.
    Y는 가수분해 또는 촉매 환원에 의하여 제거될 수 있는 보호기이고, 그리고 m 및 n은 각각 1 또는 2를 의미함).
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810004142A 1980-10-31 1981-10-29 두고리 화합물의 제조방법 KR880000890B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019860009085A KR880001007B1 (ko) 1980-10-31 1986-10-29 비사이클릭 화합물의 제조 방법

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP55154394A JPS5777651A (en) 1980-10-31 1980-10-31 Indane derivative and its preparation
US154394/1980 1980-10-31
US64371/1981 1981-04-28
JP56064371A JPS57179141A (en) 1981-04-28 1981-04-28 Bicyclic compound and its preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019860009085A Division KR880001007B1 (ko) 1980-10-31 1986-10-29 비사이클릭 화합물의 제조 방법

Publications (2)

Publication Number Publication Date
KR830007514A true KR830007514A (ko) 1983-10-21
KR880000890B1 KR880000890B1 (ko) 1988-05-30

Family

ID=26405485

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004142A KR880000890B1 (ko) 1980-10-31 1981-10-29 두고리 화합물의 제조방법

Country Status (19)

Country Link
US (3) US4822818A (ko)
EP (1) EP0051391B1 (ko)
KR (1) KR880000890B1 (ko)
AU (1) AU543804B2 (ko)
CA (1) CA1287444C (ko)
DE (1) DE3165862D1 (ko)
DK (1) DK164917C (ko)
ES (3) ES8306710A1 (ko)
FI (1) FI73698C (ko)
GB (1) GB2086393B (ko)
GR (1) GR75368B (ko)
HK (1) HK19887A (ko)
HU (1) HU183652B (ko)
IE (1) IE51918B1 (ko)
MY (1) MY8500500A (ko)
NO (1) NO155133C (ko)
NZ (1) NZ198826A (ko)
PH (2) PH18357A (ko)
PT (1) PT73912B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610816A (en) * 1980-12-18 1986-09-09 Schering Corporation Substituted dipeptides as inhibitors of enkephalinases
US4906615A (en) * 1980-12-18 1990-03-06 Schering Corporation Substituted dipeptides as inhibitors of enkephalinases
AT387717B (de) * 1983-03-16 1989-03-10 Immuno Ag Verfahren zum bestimmen von unvertraeglichkeitsreaktionen verursachenden substanzen in therapeutisch und prophylaktisch anzuwendenden blutprodukten sowie verwendung des verfahrens
US4666906A (en) * 1983-03-16 1987-05-19 Usv Pharmaceutical Corporation Compounds for treating hypertension
US4596791A (en) * 1983-03-16 1986-06-24 Usv Pharmaceutical Corp. Compounds for treating hypertension
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
EP0187037A3 (en) * 1984-12-21 1988-03-23 Takeda Chemical Industries, Ltd. Piperidine derivatives, their production and use
JPS64100A (en) * 1987-03-04 1989-01-05 Takeda Chem Ind Ltd Production of indane derivative
EP0284510A3 (en) * 1987-03-24 1990-08-22 Asahi Breweries, Ltd. N-[N alpha-(1(S)-carboxy-3-cyclohexyl-propyl)-1-lysyl] N-cyclopentylglycine as antihypertensives
US4956490A (en) * 1989-03-09 1990-09-11 Merck & Co., Inc. Process for preparing benzylpyruvic acids and esters
IT1232160B (it) * 1989-07-31 1992-01-25 Sigma Tau Ind Farmaceuti 2-(n-acil)ammino-6,7-dimetossi tetraline, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' antiipertensiva che le contengono
DE4021108A1 (de) * 1990-07-03 1992-01-09 Bayer Ag Optisch aktive n-(alpha)-fluoracryloyl-aminosaeure-derivate, ihre herstellung, die daraus hergestellten optisch aktiven polymeren und deren verwendung zur spaltung von racematen
DE4123248C2 (de) * 1991-07-13 1996-03-07 Degussa Verfahren zur Herstellung von N-substituierten alpha-Aminosäuren und alpha-Aminosäure-Derivaten
US5977160A (en) * 1992-04-10 1999-11-02 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
KR20030046079A (ko) * 2001-12-05 2003-06-12 주식회사 코오롱 고순도 염산 델라프릴의 신규한 정제방법
US7442796B2 (en) * 2003-04-30 2008-10-28 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7923467B2 (en) * 2003-05-30 2011-04-12 Ranbaxy Laboratories, Inc. Substituted pyrrole derivatives and their use as HMG-CO inhibitors
WO2007054896A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
ITMI20061364A1 (it) * 2006-07-13 2008-01-14 Dipharma Spa Procedimento per la preparazione di delapril
CL2007002044A1 (es) * 2006-07-14 2008-06-13 Ranbaxy Lab Ltd Polimorfo cristalino de la sal hemicalcica del acido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3,5-dihidroxiheptanoico; composicion farmaceutica; y uso para el tratamiento de la diabetes, enf
WO2014202659A1 (en) 2013-06-21 2014-12-24 Sanofi-Aventis Deutschland Gmbh Process for the preparation of amides of n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanine
CA3218884A1 (en) * 2021-05-11 2022-11-17 David Nutt Therapeutic aminoindane compounds and compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
FR2395998A1 (fr) * 1977-06-29 1979-01-26 Yoshitomi Pharmaceutical Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
US4316896A (en) * 1978-09-07 1982-02-23 Merck & Co., Inc. Aminoacid derivatives as antihypertensives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4256761A (en) * 1979-07-13 1981-03-17 Usv Pharmaceutical Corporation Antihypertensive amides
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
DE3040021A1 (de) * 1980-10-23 1982-05-13 Windmöller & Hölscher, 4540 Lengerich Vorrichtung zum bilden und stapeln von von einer folienschlauchbahn abgetrennten abschnitten
US4820729A (en) * 1981-03-30 1989-04-11 Rorer Pharmaceutical Corporation N-substituted-amido-amino acids

Also Published As

Publication number Publication date
IE812471L (en) 1982-04-30
CA1287444C (en) 1991-08-06
PH18357A (en) 1985-06-05
PT73912A (en) 1981-11-01
NO155133B (no) 1986-11-10
US4474692A (en) 1984-10-02
NZ198826A (en) 1984-07-06
DE3165862D1 (en) 1984-10-11
ES515269A0 (es) 1983-12-01
EP0051391B1 (en) 1984-09-05
KR880000890B1 (ko) 1988-05-30
FI73698C (fi) 1987-11-09
PH21390A (en) 1987-10-15
ES8401445A1 (es) 1983-12-01
GB2086393A (en) 1982-05-12
IE51918B1 (en) 1987-04-29
ES8504671A1 (es) 1985-05-01
FI813383L (fi) 1982-05-01
NO155133C (no) 1987-02-18
DK164917B (da) 1992-09-07
HU183652B (en) 1984-05-28
US5098892A (en) 1992-03-24
GB2086393B (en) 1984-01-11
AU543804B2 (en) 1985-05-02
PT73912B (en) 1983-01-25
NO813662L (no) 1982-05-03
DK164917C (da) 1993-02-01
US4822818A (en) 1989-04-18
MY8500500A (en) 1985-12-31
DK478181A (da) 1982-05-01
ES506714A0 (es) 1983-06-01
AU7652181A (en) 1982-05-06
EP0051391A1 (en) 1982-05-12
FI73698B (fi) 1987-07-31
GR75368B (ko) 1984-07-13
ES8306710A1 (es) 1983-06-01
ES524148A0 (es) 1985-05-01
HK19887A (en) 1987-03-13

Similar Documents

Publication Publication Date Title
KR830007514A (ko) 두고리 화합물의 제조방법
KR830010060A (ko) 술포네이트 유도체의 제조법
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR870010078A (ko) 신규의 아미노산 유도체 및 그의 제조방법
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR860001064A (ko) β-락탐 화합물의 제조방법
KR860008111A (ko) 인딘과 나프탈렌 유도체의 제조방법
KR880701233A (ko) 새로운 비페닐 유도체와 그의 제조 방법 및 용도
KR850007257A (ko) 테트라 하이드로 퀴놀린-1-알카보닐 이미다졸 유도체의 제조방법
KR850002460A (ko) 카르바메이트 화합물의 제조방법
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
KR830007601A (ko) 티아졸린 유도체의 제조방법
KR860001795A (ko) 트리아진 유도체의 제조방법
KR920701144A (ko) 아미노산 유도체
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
KR850005435A (ko) 3-알콕시-2-(n-피롤리디노)-n-피리미디닐-또는 n-피라지닐 프로필아민의 제조방법
KR900007776A (ko) 나프탈렌 유도체의 제조방법
KR850007247A (ko) 바이페닐릴설포닐 우레아의 제조방법
KR840006211A (ko) 가교 결합된 헥사하이드로벤즈[f]이소퀴놀린의 제조방법
KR870004982A (ko) 피페라진 유도체의 제조방법
KR860003224A (ko) N-벤조일 페닐 우레아의 제조방법
KR850008493A (ko) N-포르밀-디티오포스폰산 아미드의 제조방법
KR870006836A (ko) 브라시노 라이드 유사체의 제조방법